# Dose, Safety, and Pathogenicity of a New Influenza A H3N2 Challenge Strain

> **NCT06613737** · NA · COMPLETED · sponsor: **Hvivo** · enrollment: 33 (actual)

## Conditions studied

- Influenza A H3N2

## Interventions

- **OTHER:** Influenza A H3N2 virus dose arm 1
- **OTHER:** Influenza A H3N2 virus dose arm 2
- **OTHER:** Influenza A H3N2 virus dose arm 3

## Key facts

- **NCT ID:** NCT06613737
- **Lead sponsor:** Hvivo
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-11
- **Primary completion:** 2025-03-10
- **Final completion:** 2025-03-10
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06613737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06613737, "Dose, Safety, and Pathogenicity of a New Influenza A H3N2 Challenge Strain". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06613737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*